Zai Lab (ZLAB) Receivables (2018 - 2026)
Zai Lab's (ZLAB) quarterly Receivables came in at $54.1 million in Q1 2026, down 29.37% year-on-year from $76.6 million in Q1 2025, and down 49.05% quarter-over-quarter from $106.1 million in Q4 2025.
Zai Lab (ZLAB) Receivables (2018 - 2026) Analysis & Trends
Zai Lab has disclosed Receivables across 9 years of filings, most recently posting $54.1 million for Q1 2026.
- Receivables for Q1 2026 came in at $54.1 million, down 29.37% year-over-year; the trailing twelve-month figure through Mar 2026 was $54.1 million (down 29.37% YoY), and the FY2025 annual result was $106.1 million, up 24.58% from the prior year.
- Receivables came in at $54.1 million for Q1 2026 at Zai Lab, down from $106.1 million in the prior quarter.
- In the past five years, Receivables ranged from a high of $106.1 million in Q4 2025 to a low of $27.1 million in Q2 2022.
- The 5-year median for Receivables is $54.1 million (2026), against an average of $58.6 million.
- Across the five-year window, Receivables soared 278.83% in 2022 and dropped 29.37% in 2026, its largest moves.
- Zai Lab's Receivables stood at $40.0 million in 2022, then surged by 48.13% to $59.2 million in 2023, then jumped by 43.88% to $85.2 million in 2024, then rose by 24.58% to $106.1 million in 2025, then plunged by 49.05% to $54.1 million in 2026.
- The last three Receivables figures came in at $54.1 million (Q1 2026), $106.1 million (Q4 2025), and $85.4 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 13.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 2.00 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Zai Lab | 20.15 Bn | 20.05 Bn | 61.30 Mn | 54.07 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 54.07 Mn |
| Dec 31, 2025 | 106.12 Mn |
| Sep 30, 2025 | 85.38 Mn |
| Jun 30, 2025 | 88.50 Mn |
| Mar 31, 2025 | 76.56 Mn |
| Dec 31, 2024 | 85.18 Mn |
| Sep 30, 2024 | 49.97 Mn |
| Jun 30, 2024 | 69.64 Mn |
| Mar 31, 2024 | 60.42 Mn |
| Dec 31, 2023 | 59.20 Mn |
| Sep 30, 2023 | 41.60 Mn |
| Jun 30, 2023 | 47.28 Mn |
| Mar 31, 2023 | 43.35 Mn |
| Dec 31, 2022 | 39.96 Mn |
| Sep 30, 2022 | 27.74 Mn |
| Jun 30, 2022 | 27.05 Mn |
| Mar 31, 2022 | 33.39 Mn |
| Dec 31, 2021 | 47.47 Mn |
| Sep 30, 2021 | 21.02 Mn |
| Jun 30, 2021 | 18.03 Mn |